Literature DB >> 18723087

Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers.

Soo Hyeon Lee1, Ki Hyun Bae, Sun Hwa Kim, Kyu Ri Lee, Tae Gwan Park.   

Abstract

Gold nanoparticles chemically modified with primary amine groups were developed as intracellular delivery vehicles for therapeutic small interfering RNA (siRNA). The positively charged gold nanoparticles could form stable polyelectrolyte complexes through electrostatic interactions with negatively charged siRNA-polyethylene glycol (PEG) conjugates having a cleavable di-sulfide linkage under reductive cytosol condition. The resultant core/shell type polyelectrolyte complexes surrounded by a protective PEG shell layer had a well-dispersed nanostructure with a hydrodynamic diameter of 96.3+/-25.9 nm, as determined by dynamic light scattering and transmission electron microscopy. Confocal laser scanning microscopy revealed that the nanosized polyelectrolyte complexes were efficiently internalized in human prostate carcinoma cells, and thus enhanced intracellular uptake of siRNA. Furthermore, the siRNA/gold complexes significantly inhibited the expression of a target gene within the cells without showing severe cytotoxicity. The current study demonstrated that positively charged gold nanoparticles could be potentially applied for intracellular delivery of siRNA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723087     DOI: 10.1016/j.ijpharm.2008.07.027

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  35 in total

1.  Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles.

Authors:  Pinal C Patel; David A Giljohann; Weston L Daniel; Dan Zheng; Andrew E Prigodich; Chad A Mirkin
Journal:  Bioconjug Chem       Date:  2010-11-11       Impact factor: 4.774

2.  Preparation, physicochemical characterization and performance evaluation of gold nanoparticles in radiotherapy.

Authors:  Ali Kamiar; Reza Ghotalou; Hadi Vali Zadeh
Journal:  Adv Pharm Bull       Date:  2013-08-20

Review 3.  Self-assembled and nanostructured siRNA delivery systems.

Authors:  Ji Hoon Jeong; Tae Gwan Park; Sun Hwa Kim
Journal:  Pharm Res       Date:  2011-03-18       Impact factor: 4.200

Review 4.  Gold nanoparticles in cancer therapy.

Authors:  Zhao-Zhin Joanna Lim; Jia-En Jasmine Li; Cheng-Teng Ng; Lin-Yue Lanry Yung; Boon-Huat Bay
Journal:  Acta Pharmacol Sin       Date:  2011-07-11       Impact factor: 6.150

5.  Inorganic nanovectors for nucleic acid delivery.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Anisha A D'Souza; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2013-10       Impact factor: 4.617

Review 6.  Rigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.

Authors:  Zhiyong Wang; Gang Liu; Hairong Zheng; Xiaoyuan Chen
Journal:  Biotechnol Adv       Date:  2013-09-05       Impact factor: 14.227

7.  Spatiotemporal temperature distribution and cancer cell death in response to extracellular hyperthermia induced by gold nanorods.

Authors:  Huang-Chiao Huang; Kaushal Rege; Jeffrey J Heys
Journal:  ACS Nano       Date:  2010-05-25       Impact factor: 15.881

Review 8.  Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.

Authors:  Anish Babu; Ranganayaki Muralidharan; Narsireddy Amreddy; Meghna Mehta; Anupama Munshi; Rajagopal Ramesh
Journal:  IEEE Trans Nanobioscience       Date:  2016-12       Impact factor: 2.935

9.  Gold nanoprobes for theranostics.

Authors:  Balaji Panchapakesan; Brittany Book-Newell; Palaniappan Sethu; Madhusudhana Rao; Joseph Irudayaraj
Journal:  Nanomedicine (Lond)       Date:  2011-12       Impact factor: 5.307

10.  Enhanced delivery of biodegradable mPEG-PLGA-PLL nanoparticles loading Cy3-labelled PDGF-BB siRNA by UTMD to rat retina.

Authors:  Jing DU; Ying Sun; Feng-Hua Li; Lian-Fang DU; You-Rong Duan
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.